InvestorsObserver
×
News Home

Is Arcellx Inc (ACLX) a Leader in the Biotechnology Industry?

Wednesday, November 29, 2023 12:09 PM | InvestorsObserver Analysts

Mentioned in this article

Is Arcellx Inc (ACLX) a Leader in the Biotechnology Industry?

A rating of 86 puts Arcellx Inc (ACLX) near the top of the Biotechnology industry according to InvestorsObserver. Arcellx Inc's score of 86 means it scores higher than 86% of stocks in the industry. Arcellx Inc also received an overall rating of 67, putting it above 67% of all stocks. Biotechnology is ranked 54 out of the 148 industries.

Overall Score - 67
ACLX has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on ACLX!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 67 would rank higher than 67 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Arcellx Inc Stock Today?

Arcellx Inc (ACLX) stock is down -0.74% while the S&P 500 has gained 0.16% as of 12:08 PM on Wednesday, Nov 29. ACLX is lower by -$0.38 from the previous closing price of $51.10 on volume of 152,076 shares. Over the past year the S&P 500 is higher by 15.28% while ACLX has gained 153.98%. ACLX lost -$2.78 per share the over the last 12 months. Click Here to get the full Stock Report for Arcellx Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App